Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rheumacalm is a proprietary Ayurvedic herbal formulation developed by Vaidyaratnam Oushadhasala. It is traditionally used to manage joint and muscle discomfort associated with various musculoskeletal and arthritic conditions, including rheumatoid arthritis, osteoarthritis, gout, sciatica, lumbago, sprains, bursitis, and neuralgia. The formulation contains a synergistic blend of potent Ayurvedic herbs such as Guggulu (Commiphora mukul), Rasna (Pluchea lanceolata), Eranda (Ricinus communis), and Shallaki (Boswellia serrata), which provide anti-inflammatory, analgesic, and anti-rheumatic properties. Rheumacalm helps reduce joint pain and swelling, alleviate muscle spasms, and improve overall joint mobility and flexibility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rheumacalm.